Titre:
  • Study protocol for THINK: A multinational open-label phase i study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types
Auteur:Lonez, Caroline; Verma, B.; Hendlisz, Alain; Aftimos, Philippe; Awada, Ahmad; Van Den Neste, Eric; Catala, Gaetan; Machiels, Jean Pascal J.P.H.; Piette, Fanny; Brayer, Jason J.B.; Sallman, David D.A.; Kerre, Tessa; Odunsi, K.; Davila, Marco M.L.; Gilham, D.E.; Lehmann, F.F.
Informations sur la publication:BMJ open, 7, 11, e017075
Statut de publication:Publié, 2017-11
Sujet CREF:Droit
Mots-clés:car-t
chimeric antigen receptor
multiple injections
nkg2d
nkr-2
solid tumours
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:2044-6055
info:doi/10.1136/bmjopen-2017-017075
info:scp/85043324884
info:pmid/29133316